SCHEMBL210501

SCHEMBL210501

CC(C)(C)[Si](C)(C)O[C@H]1CC[C@@H](N2CC[C@@H](Cc3c(Cl)cc(-c4ccc(C(=O)N5CCC(F)(F)CC5)cc4)cc3Cl)C2=O)CC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.34
HTR1A P08908 6/20 0.34
MET P08581 4/20 0.33
FASN P49327 1/20 0.33
HRH1 P35367 2/20 0.32
CCR3 P51677 2/20 0.32
PDE5A O76074 1/20 0.32
PDE4A P27815 1/20 0.32
PDE1A P54750 1/20 0.32
PDE1B Q01064 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
PDE7A Q13946 1/20 0.32
PDE1C Q14123 1/20 0.32
PDE3A Q14432 1/20 0.32
PDE7B Q9NP56 1/20 0.32
GABRA5 P31644 1/20 0.32
CYP2D6 P10635 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL210500 1.00 LRRK2 (0.34) LRRK2HTR1AMETFASNHRH1
SCHEMBL210502 1.00 LRRK2 (0.34) LRRK2HTR1AMETFASNHRH1
SCHEMBL210053 0.96 HSP90AA1 (0.33) LRRK2HTR1AMET
SCHEMBL210052 0.96 HSP90AA1 (0.33) LRRK2HTR1AMET
SCHEMBL210051 0.96 HSP90AA1 (0.33) LRRK2HTR1AMET
SCHEMBL208996 0.90 MET (0.40) METHRH3
SCHEMBL208995 0.90 MET (0.40) METHRH3
SCHEMBL210979 0.90 HRH3 (0.40) LRRK2METHRH1HRH3NPSR1
SCHEMBL210980 0.90 HRH3 (0.40) LRRK2METHRH1HRH3NPSR1
SCHEMBL208200 0.90 HRH3 (0.40) LRRK2METHRH1HRH3NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2016047-B1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-08-28 EP disclosed
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US disclosed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD11B2 LRRK2 2036/4885HTR1A 173/4885MET 2704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.